PR and marketing consultancy with a thirst for all things interesting! 'The important thing is to not stop questioning' Albert Einstein" title="" class="btn" data-container="body" data-html="true" data-id="214576" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#b3d4fc" tabindex="0" data-original-title="VanePercy&Roberts"> 489 144
Activities
Entity types
Location
Robert Denholm House, Bletchingley Rd, Nutfield RH1 4HW, UK
Nutfield
United Kingdom
Employees
Scale: 2-10
Estimated: 9
Engaged corporates
1Added in Motherbase
2 years, 8 months agoVane Percy & Roberts is a healthcare and science communications consultancy led by two partners, Simon Vane Percy and Sarah Roberts. All accounts are directed by Simon or Sarah and supported by the very experienced VPR team.
This hands-on approach which gives all clients access to the senior team members is relatively unique in PR. It is, however, what makes us stand out from the crowd and successful in what we do. We have worked for a wide variety of clients spanning a number of sectors. However, we focus on activities which achieve positive results rather than offering an ‘off the shelf’ solution. We are more than aware that you are only as good as the job you do for each individual client.
We don’t mean for this to sound ‘apple pie’. It is genuinely the way we run the business.
So, if you are in need of a communications partner who will work hard to understand your business and how we can help you achieve your objectives then why not give us a call? Its amazing what can come out of a chat!
(T) +44(0)1737 821890
(e) sarah@vanepercy.com
Marketing, Communications, Public Relations, Corporate Strategy, Events Management, Media and editorial, Stakeholder relations, KOL relationship development, Patient advocacy, Strategy, and Crisis and Issue Management
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
![]() FirstWord Pharma Pharmaceutical, Pharmaceutical Manufacturing | FirstWord Pharma Pharmaceutical, Pharmaceutical Manufacturing | Other 29 Sep 2017 | |